ProfileGDS4459 / ENSG00000108557
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 45% 39% 50% 42% 46% 58% 47% 36% 47% 47% 41% 51% 46% 41% 50% 29% 33% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.2545
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.0539
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 34.3650
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.2542
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.2546
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.758
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.3247
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.836
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 94.2547
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.3347
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.9741
GSM623475group B, liver allograft wedge biopsie placebo treatment 24.4251
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.2846
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.1241
GSM623478group B, liver allograft wedge biopsie placebo treatment 54.3650
GSM623479group B, liver allograft wedge biopsie placebo treatment 63.7329
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.8433